Pre-Clinical Development of a Highly Efficient TALEN ®-Based Correction of the Β-Globin Gene in Patient-Derived Hematopoietic Stem and Progenitor Cells (hspcs) to Treat Sickle Cell Disease
BLOOD(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined